What to Expect for Monsanto's 4Q17 Earnings

1 2 3 4 5 6 7
Part 7
What to Expect for Monsanto's 4Q17 Earnings PART 7 OF 7

Analysts’ Pre-4Q17 Views on Monsanto

Analysts’ views

Now that we’ve looked at analysts’ estimates for Monsanto’s (MON) 4Q17, let’s look at their consensus recommendations and price target for Monsanto over the next 12 months.

Analysts&#8217; Pre-4Q17 Views on Monsanto

Interested in FMC? Don't miss the next report.

Receive e-mail alerts for new research on FMC

Success! You are now receiving e-mail alerts for new research. A temporary password for your new Market Realist account has been sent to your e-mail address.

Success! has been added to your Ticker Alerts.

Success! has been added to your Ticker Alerts. Subscriptions can be managed in your user profile.

Analysts’ ratings

On September 22, analysts’ consensus rating for Monsanto stock was 2.5, with an overall “buy” recommendation for the next 12 months. As shown in the chart above, three analysts have recommended “strong buy,” eight have recommended “buy,” seven have recommended “hold,” and just one has recommended “sell.” It’s not uncommon to see fewer “sell” recommendations from sell-side analysts.

Price target

Analysts’ consensus price target for Monsanto for the next 12 months is $128 per share, which is Bayer’s acquisition price for the company. On September 22, Monsanto’s stock closed at $119.80, which is almost 7% lower than its target price.

To follow analysts’ ratings and price targets for Monsanto and other agribusiness companies (XLB) such as FMC (FMC), Scotts Miracle-Gro (SMG), and PotashCorp (POT), read our monthly analyst rating series. Our latest is What Analysts Recommend for Agricultural Chemical Stocks.



Please select a profession that best describes you: